Kolexia
Hamidou Hadji
Radio-thérapie
Ico - Site Paul Papin
Angers, France
37 Activités
42 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Métastase tumorale Carcinomes Tumeurs de l'oesophage Carcinome épidermoïde Néphrocarcinome Tumeurs du rachis Tumeurs de l'anus Tumeurs de la tête et du cou Tumeurs du système nerveux central

Industries

Ipsen
4 collaboration(s)
Dernière en 2023
PASCALEO
2 collaboration(s)
Dernière en 2022
Bayer
1 collaboration(s)
Dernière en 2022
Janssen
1 collaboration(s)
Dernière en 2022

Dernières activités

GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Acta oncologica (Stockholm, Sweden)   20 juin 2023
GETUG-AFU 22 Phase II Randomized Trial Evaluating Outcomes of Post-Operative Immediate Salvage Radiation Therapy with or without ADT for Patients with Persistently Elevated PSA Level
A Red Journal Special IssueOligometastasis, Part 2   01 décembre 2022
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
Cancers   09 juin 2020
Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/- 6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical Prostatectomy
Proceedings of the Amercian Society for Radiation Oncology 61st Annual Meeting   01 septembre 2019
The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.
2017 Genitourinary Cancers Symposium   29 mars 2017
High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study.
International journal of radiation oncology, biology, physics   30 juillet 2016
Radiothérapie hypofractionnée à fortes doses de métastases osseuses vertébrales non compressives en association avec l’acide zolédronique : étude de phase 1 multicentrique et prospective
26e Congrès national de la Société française de radiothérapie oncologique SFRO)   01 octobre 2015
Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?
Journal of surgical oncology   28 novembre 2011
Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   25 novembre 2011